Purchase Order N0017313P0972
- Not listed
- The Bureau of Medicine and Surgery awarded a $18,034 firm fixed-price purchase order to Biofire Defense LLC on December 3, 2024, for the BIOFIRE DEFENSE PRODUCT NGDS-ASY-0017. The contract, which requires completion by February 28, 2025, will be performed in Frederick, Maryland. This purchase order represents a tactical procurement from Biofire Defense, a Salt Lake City-based manufacturer specializing in molecular diagnostic technologies and biological agent identification products. No set-aside...
- This firm-fixed-price purchase order was awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is for the delivery of Biofire FilmArray 2.0 complete systems, a molecular diagnostic technology used for rapid pathogen detection and infectious disease testing. The contract has a ceiling value of $39,206.77 and a period of performance ending on April 24, 2020. This contract award is...
- The Bureau of Medicine and Surgery awarded a $102,344 firm fixed-price purchase order to Biofire Defense LLC on July 22, 2024, for FilmArray Respiratory Panels 2.1. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2025, with performance taking place in Peru. Biofire Defense LLC, a Salt Lake City-based limited liability company specializing in molecular diagnostic technologies, has established itself as a key federal vendor for infectious...
- The U.S. Bureau of Medicine and Surgery awarded a $122,832 firm fixed-price purchase order to Biofire Defense LLC on May 24, 2023, for FilmArray Respiratory 2.1 panels, with completion targeted for June 9, 2023. The contract is not designated as a set-aside award and specifies Peru as the place of performance. Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, is a key federal vendor specializing in rapid infectious disease identification products. The...
- This federal contract award, with the identification number N0017319P0033, was issued by the Office of Naval Research (ONR) to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract, which is a Firm Fixed Price Purchase Order, is for "PATHOGEN TESTING PR# 69-4302-18" and has a ceiling value of $15,035.23. The contract does not have a set-aside designation and has an ultimate completion date of November 16, 2018. Biofire Defense LLC is...
- This is a fixed-price purchase order awarded by the U.S. Navy's Bureau of Medicine and Surgery to Biofire Defense LLC, a manufacturer of biological agent identification products including the Biofire FilmArray system. The $147,187.63 contract is for the provision of Film Array Equipment #1, with a performance period ending on December 8, 2016. Biofire Defense LLC is a for-profit limited liability company that has previously received federal prime contracts and grants related to biological threat...
- This is a $337,500 firm-fixed-price delivery order awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Biofire Defense LLC, a limited liability company that manufactures biological agent identification products. The order is for the purchase of Biofire's FilmArray diagnostic system laptops, which are FDA-cleared instruments. This delivery order is part of a larger indefinite delivery contract awarded to Biofire Defense in September 2023...
- This is a firm fixed-price purchase order contract awarded by the U.S. Navy's Bureau of Medicine and Surgery to Biofire Defense LLC, a manufacturer of biological agent identification products. The contract, valued at $86,738.00, is for Film Array maintenance services. Biofire Defense previously received other federal contracts and grants related to biological threat detection, infectious disease testing, and COVID-19 response, including a $6.2 million cooperative agreement to expand...
- This federal contract award to Biofire Defense LLC, a limited liability company that manufactures biological agent identification products, is for the delivery of FilmArray 2.0 diagnostic systems, GI panel test kits, and respiratory panel test kits to the U.S. Navy Bureau of Medicine and Surgery. The contract is a firm fixed-price purchase order with a ceiling value of $148,173.60 and a period of performance through September 29, 2017. There is no set-aside designation for this award. Biofire...
- The Department of Defense's Joint Program Executive Office for Chemical and Biological Defense awarded a delivery order valued at $207,157 to Biofire Defense LLC on September 9, 2025, for global fever panels and associated control kits. The delivery order, which carries no set-aside designation and operates under a firm fixed-price structure, is scheduled for completion by December 15, 2025. Biofire Defense, a Salt Lake City-based manufacturer of molecular diagnostic technologies established...
The Office of Naval Research awarded a $51,110 firm fixed-price purchase order to Biofire Defense LLC on April 2, 2013, for a Film Array System, with an ultimate completion date of May 2, 2013. The contract, which carries no set-aside designation, procures the company's advanced molecular diagnostic technology platform designed to support biodefense and infectious disease detection capabilities. Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies headquartered in Emigration Canyon, Utah, specializes in rapid pathogen identification systems and has been an established federal contractor since 2001, serving as a critical vendor across the Department of Defense, Department of State, National Institutes of Health, and other federal agencies. This purchase order reflects the government's continued investment in Biofire Defense's core product portfolio, which includes the FilmArray diagnostic system and associated test panels for respiratory, gastrointestinal, and specialized pathogen detection. The company's Film Array systems serve critical biodefense missions by enabling rapid, multiplex molecular analysis capabilities at military and federal medical facilities. Biofire Defense's established federal contracting relationships and expertise in diagnostic solutions have made it a preferred vendor for government biodefense preparedness and medical readiness requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.1k | 4/1/13 |